In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meda AB

Division of Mylan NV
www.meda.se

Latest From Meda AB

Appointments: Changes at SOTIO, Helsinn, Sobi, AMRI, Blade and Vertex

The latest biopharma industry appointments include a new chairman at Bone Therapeutics, chief executives at SOTIO and Helsinn Therapeutics, new CFOs at Sobi, AMRI and at Blade Therapeutics, and a new CMO at Vertex Pharmaceuticals.

Appointments Companies

Australian Court Restrains Apotex Challenge To Cipla-Meda’s Dymista

Apotex’s plans to launch a nasal spray formulation that competes with Cipla-Meda’s Dymista has been blocked by the Federal Court of Australia, at least for now. Apotex has challenged the validity of certain claims of the patent pertaining to Dymista.

Commercial Companies

Australian Court Restrains Apotex Challenge To Cipla-Meda’s Dymista

Apotex’s plans to launch a nasal spray formulation that competes with Cipla-Meda’s Dymista has been blocked by the Federal Court of Australia, at least for now. Apotex has challenged the validity of certain claims of the patent pertaining to Dymista.

Commercial Companies

Deal Watch: Gilead And Spring Bank Set Second Trial Collaboration In HBV

Analyst speculates that Gilead could move to acquire Spring Bank if combo trial yields promising data for functional cure of hepatitis B. Eisai in-licenses PARP inhibitor with potential in breast cancer from Oncology Venture, while Sunovion out-licenses three corticosteroid products to Covis.

Deals Commercial
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register